Allergy medication effects on dental treatment are more significant than many patients realise. Millions of people across the UK take antihistamines, corticosteroid nasal sprays, and decongestants to manage hay fever, allergic rhinitis, and urticaria — yet these medicines can meaningfully affect oral health and dental procedures. From dry mouth caused by anticholinergic antihistamines to potential interactions between decongestants and adrenaline-containing local anaesthetics, understanding these effects helps both patients and dental teams plan safer, more effective care. This article explains what you need to know before your next dental appointment.

How Common Allergy Medications Can Affect Your Mouth and Teeth

Allergy medications are among the most widely used medicines in the UK, with millions of people taking antihistamines, corticosteroid nasal sprays, and decongestants to manage conditions such as hay fever, allergic rhinitis, and urticaria. While these medicines are generally safe and effective, they can have a range of effects on oral health and dental treatment that both patients and clinicians should be aware of.

First-generation antihistamines — such as chlorphenamine (Piriton) — reduce saliva production primarily through their anticholinergic (antimuscarinic) activity, which inhibits secretion from the salivary glands. This can lead to a dry mouth (xerostomia). Their sedating properties arise separately, from central histamine H1 receptor blockade. Second-generation antihistamines, including cetirizine, loratadine, and fexofenadine, have much lower anticholinergic activity and are less likely to cause xerostomia, though it can still occur — particularly at higher doses or in susceptible individuals.

Corticosteroid nasal sprays such as beclometasone and fluticasone are commonly prescribed or purchased over the counter for allergic rhinitis. Oral candidiasis (thrush) is a recognised adverse effect of inhaled corticosteroids (used for asthma), and patients using these should use a spacer device where possible and rinse their mouth with water and spit out after each use. The risk with intranasal corticosteroids alone is considerably lower, provided correct technique is used (directing the spray away from the nasal septum and avoiding swallowing the spray). Decongestants such as pseudoephedrine are sympathomimetic agents that cause vasoconstriction; this is particularly relevant in patients with hypertension or cardiovascular disease, and may have implications when adrenaline-containing local anaesthetics are used during dental procedures.

Understanding how these medications interact with oral physiology is an important first step in ensuring safe and effective dental care. Patients are often unaware that allergy treatments — including those bought without a prescription — can influence their dental health and the outcome of dental procedures.

Dry Mouth, Bleeding Risk, and Other Dental Side Effects

Dry mouth is one of the most clinically significant oral side effects associated with allergy medications. Saliva plays a critical role in protecting the teeth and oral mucosa: it neutralises acids, remineralises enamel, and provides antimicrobial protection. When saliva flow is reduced — as can occur with first-generation antihistamines due to their anticholinergic effects — patients face an increased risk of:

• Dental caries (tooth decay), especially at the gum line and between teeth

• Oral candidiasis, particularly in patients also using inhaled corticosteroids

• Halitosis (bad breath) due to reduced bacterial clearance

• Difficulty wearing dentures, as saliva acts as a natural adhesive and cushion

• Mucosal soreness and ulceration, due to reduced lubrication

For patients at high risk of caries due to dry mouth, evidence-based preventive measures include the use of high-fluoride toothpaste (5,000 ppm fluoride for high-risk adults, as recommended in Delivering Better Oral Health published by the Office for Health Improvements and Disparities), fluoride varnish application, dietary counselling to reduce sugar frequency, and the use of saliva substitutes or stimulants (such as sugar-free gum containing xylitol).

Some patients with allergic conditions also take leukotriene receptor antagonists such as montelukast, or are prescribed aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) for associated inflammatory conditions. It is important to distinguish between these: aspirin irreversibly inhibits platelet aggregation and has the most significant effect on bleeding risk. Most other NSAIDs cause a reversible, modest reduction in platelet function, and in the majority of cases they can be continued for routine dental procedures, with appropriate local haemostatic measures applied. Patients should not stop prescribed medicines without seeking professional advice. The dental team should be informed of all medicines being taken so that an individual assessment can be made.

Long-term use of systemic corticosteroids — occasionally prescribed for severe allergic conditions — can suppress the hypothalamic-pituitary-adrenal (HPA) axis. For most routine dental procedures carried out under local anaesthetic, additional steroid supplementation is not routinely required. However, for more significant surgical procedures, treatment under sedation or general anaesthesia, or where there is clinical uncertainty, the dental team should liaise with the patient's GP or endocrinologist and follow the NHS Steroid Emergency Card guidance (introduced in 2020) and current Society for Endocrinology recommendations. Patients on long-term systemic steroids should always carry their Steroid Emergency Card and inform their dental team.

Telling Your Dentist About Allergy Medications Before Treatment

Accurate and complete medication disclosure is a fundamental aspect of safe dental care. Patients frequently underestimate the relevance of over-the-counter (OTC) allergy treatments, assuming that only prescription medicines need to be declared. In reality, OTC antihistamines, nasal sprays, and decongestants can all influence dental treatment planning and outcomes.

Before any dental procedure, patients should inform their dentist of:

• All antihistamines (both prescription and OTC), including the dose and frequency

• Corticosteroid nasal sprays or inhalers, noting how long they have been used

• Decongestants, particularly those containing pseudoephedrine or ephedrine

• Immunotherapy treatments (allergen desensitisation injections or sublingual drops) — invasive dental procedures are best avoided on the same day as a subcutaneous immunotherapy (SCIT) injection; if uncertain, liaise with the allergy clinic

• Any known drug allergies or sensitivities, including reactions to local anaesthetics, antiseptics, or dental materials

This information allows the dental team to tailor their approach appropriately. For example, a patient with significant xerostomia may benefit from fluoride varnish application, saliva substitutes, or dietary advice to reduce caries risk. A patient on long-term systemic corticosteroids may require liaison with their GP before invasive procedures.

Patients with a history of allergic conditions may also have sensitivities to certain dental materials, including latex, impression materials, or nickel-containing orthodontic appliances. Many UK dental practices now use latex-free gloves and equipment as standard, but patients should still declare any known latex or material sensitivities so that appropriate precautions can be confirmed. Declaring a history of allergic conditions — even if not currently medicated — helps the dental team take the right steps.

Dental practices routinely collect and update medical histories at every visit. Patients should ensure their records are kept up to date at every appointment, not just at initial registration.

Medications That May Interact With Local Anaesthetics or Sedation

Local anaesthetics are the cornerstone of pain management in dentistry, and the most commonly used agents in UK dental practice are lidocaine, articaine, and prilocaine, often combined with a vasoconstrictor such as adrenaline. Understanding how allergy medications may interact with these agents is important for patient safety.

Decongestants containing sympathomimetic agents such as pseudoephedrine or ephedrine can potentially enhance the cardiovascular effects of adrenaline-containing local anaesthetics, with a risk of additive increases in blood pressure or heart rate. This is of particular relevance in patients with pre-existing hypertension, arrhythmias, or cardiovascular disease. The dental team should monitor blood pressure and heart rate in such patients; using the minimum effective dose of adrenaline-containing local anaesthetic is advisable, and a plain local anaesthetic (without vasoconstrictor) may be considered where clinically appropriate, bearing in mind that vasoconstrictors also help control bleeding and prolong anaesthesia.

First-generation antihistamines with sedating properties — such as chlorphenamine or promethazine — can enhance the sedative effects of agents used in conscious sedation, including midazolam or nitrous oxide. In line with the Intercollegiate Advisory Committee for Sedation in Dentistry (IACSD) Standards for Conscious Sedation in the Provision of Dental Care, patients should avoid taking sedating antihistamines on the day of a planned sedation appointment. Appropriate monitoring and a responsible adult escort are required as standard. Patients should inform their dental team of any sedating medicines they are taking.

Monoamine oxidase inhibitors (MAOIs), very occasionally used in the management of severe psychiatric or other conditions, have a theoretical interaction with sympathomimetic drugs. However, UK Medicines Information (UKMi) and BNF guidance indicates that adrenaline-containing dental local anaesthetics can generally be used with caution in patients taking MAOIs — using the minimum effective dose and monitoring blood pressure and heart rate. Indirectly acting sympathomimetics (such as ephedrine) should be avoided. If there is any uncertainty, advice should be sought from the patient's prescriber or a medicines information service before treatment.

A thorough medication review remains best practice before any procedure involving sedation or complex anaesthesia. The BNF is an essential reference for checking specific drug interactions.

UK Guidance on Managing Medications Around Dental Procedures

Several UK clinical frameworks are relevant to the management of allergy medications in the context of dental care.

Dry mouth and caries prevention: The Office for Health Improvements and Disparities (OHID) publication Delivering Better Oral Health (4th edition) provides evidence-based guidance on preventing dental caries in patients with xerostomia. Recommended measures include high-fluoride toothpaste (5,000 ppm for high-risk adults), fluoride varnish, dietary counselling, and the use of saliva substitutes or stimulants. NICE Clinical Knowledge Summaries (CKS) on dry mouth and oral candidiasis provide additional clinical background and patient-facing management advice aligned with UK practice.

Oral candidiasis: Patients using inhaled corticosteroids should use a spacer device where possible and rinse their mouth with water and spit out after each use to reduce the risk of oropharyngeal candidiasis. Those using intranasal corticosteroids should ensure correct technique. NICE CKS on oral candidiasis provides guidance on diagnosis and management.

Peri-procedural steroid management: For patients on long-term systemic corticosteroids, the NHS Steroid Emergency Card (introduced in 2020) and guidance from the Society for Endocrinology clarify when additional steroid cover may be needed. For most routine dental procedures under local anaesthetic, additional supplementation is not routinely required. For more significant surgical procedures, treatment under sedation or general anaesthesia, or where clinical uncertainty exists, the dental team should liaise with the patient's GP or specialist. The BNF provides specific guidance on steroid cover for surgical procedures.

Reporting suspected adverse reactions: The MHRA's Yellow Card scheme allows both healthcare professionals and patients to report suspected adverse drug reactions, including unexpected oral effects of allergy medications. Patients who notice new or worsening oral symptoms after starting an allergy medicine are encouraged to report these at yellowcard.mhra.gov.uk, or through their GP or pharmacist.

The BNF remains an essential reference for checking specific drug interactions before treatment, and the Specialist Pharmacy Service (SPS/UKMi) can provide medicines information support for complex cases.

When to Seek Advice From Your GP or Dental Team

Most patients taking standard allergy medications can undergo routine dental treatment safely, provided their dental team is fully informed. However, there are specific circumstances in which seeking additional advice from a GP, pharmacist, or specialist is strongly recommended before proceeding with dental care.

Seek emergency help immediately (call 999) if you experience:

• Sudden swelling of the lips, tongue, or throat

• Difficulty breathing or swallowing

• Dizziness, collapse, or loss of consciousness following any dental material or medication

These symptoms may indicate anaphylaxis, which is a medical emergency. Use NHS 111 for urgent advice that is not life-threatening.

Contact your dental team promptly if you notice:

• Persistent dry mouth that is affecting eating, speaking, or sleeping

• White patches or soreness in the mouth that may indicate oral thrush — particularly if you are using inhaled or nasal corticosteroids. To help prevent this, use a spacer device with your inhaler where possible, and rinse your mouth with water and spit out after each use

• Unusual or prolonged bleeding from the gums that does not settle within a reasonable time

Speak to your GP before dental treatment if:

• You are taking long-term systemic corticosteroids (e.g., prednisolone) and are due to have an extraction, implant, or surgical procedure — carry your NHS Steroid Emergency Card and ensure your dental team is aware

• You are undergoing allergen immunotherapy (desensitisation injections or sublingual drops), as invasive dental appointments are best not scheduled on the same day as an injection; liaise with your allergy clinic if uncertain

• You have recently changed your allergy medication regimen and are unsure of potential interactions

• You have a known allergy to any anaesthetic agent, antiseptic, or dental material

Open communication between patients, their GP, and their dental team is the most effective safeguard. Pharmacists are also an excellent first point of contact for questions about OTC allergy medicines and their potential oral effects. Patients should never stop prescribed allergy medication before dental treatment without first seeking professional advice, as this may worsen their underlying condition and create additional health risks.

Suspected side effects from any allergy medicine — including unexpected oral effects — can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Frequently Asked Questions